5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.25%
Positive revenue growth while Consumer Cyclical median is negative. Peter Lynch might see a relative strength advantage in a tough sector.
44.98%
Positive gross profit growth while Consumer Cyclical median is negative. Peter Lynch would see a notable competitive edge in cost or pricing.
21.04%
EBIT growth exceeding 1.5x Consumer Cyclical median of 1.57%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
21.04%
Operating income growth exceeding 1.5x Consumer Cyclical median of 0.21%. Joel Greenblatt would see if unique processes drive exceptional profitability.
60.67%
Net income growth exceeding 1.5x Consumer Cyclical median of 0.63%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
63.16%
EPS growth exceeding 1.5x Consumer Cyclical median of 0.41%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
63.16%
Diluted EPS growth of 63.16% while Consumer Cyclical median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
-1.53%
Diluted share reduction while Consumer Cyclical median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
No Data
No Data available this quarter, please select a different quarter.
-22.70%
Negative OCF growth while Consumer Cyclical median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-40.00%
Negative FCF growth while Consumer Cyclical median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
-8.68%
Negative 10Y revenue/share CAGR while Consumer Cyclical median is 26.48%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
25.96%
5Y revenue/share growth exceeding 1.5x Consumer Cyclical median of 12.55%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
17.83%
3Y revenue/share growth exceeding 1.5x Consumer Cyclical median of 7.27%. Joel Greenblatt might see a short-term competitive advantage at play.
182.79%
OCF/share CAGR of 182.79% while Consumer Cyclical median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
247.97%
OCF/share CAGR of 247.97% while Consumer Cyclical median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
150.87%
3Y OCF/share growth of 150.87% while Consumer Cyclical median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
731.07%
Net income/share CAGR exceeding 1.5x Consumer Cyclical median of 21.92% over a decade. Joel Greenblatt might see a standout compounder of earnings.
211.38%
5Y net income/share CAGR > 1.5x Consumer Cyclical median of 12.95%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
83.17%
3Y net income/share CAGR > 1.5x Consumer Cyclical median of 19.03%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
99.05%
Equity/share CAGR exceeding 1.5x Consumer Cyclical median of 40.52% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
57.70%
5Y equity/share CAGR > 1.5x Consumer Cyclical median of 22.59%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
31.43%
3Y equity/share CAGR > 1.5x Consumer Cyclical median of 12.16%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.89%
AR growth of 30.89% while Consumer Cyclical median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
10.56%
Inventory growth far above Consumer Cyclical median. Jim Chanos suspects major issues in demand forecasting or potential obsolescence risk.
6.44%
Asset growth exceeding 1.5x Consumer Cyclical median of 0.50%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
0.10%
Below 50% of Consumer Cyclical median. Jim Chanos suspects deeper issues blocking net worth accumulation.
4.68%
Debt growth of 4.68% while Consumer Cyclical median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
-100.00%
R&D dropping while Consumer Cyclical median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.
-3.65%
SG&A decline while Consumer Cyclical grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.